1,3-dihydro-1-(1-((4-methyl-4H,6H-pyrrolo(1,2a)(4,1)-benzoxazepin-4-yl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one,
CGS 9343B,
CGS 9343B maleate,
CGS-9343B,
KW-6517,
zaldaride maleate,
Zy 17617B,
Zy-17617B,
Cgs 9343B,
Zaldaride maleate,
109826-27-9,
KW-5617,
Zy-17617B,
CGS-9343B,
Zy 17617B,
CGS9343B,
2H-Benzimidazol-2-one, 1,3-dihydro-1-(1-((4-methyl-4H,6H-pyrrolo(1,2-a)(4,1)benzoxazepin-4-yl)methyl)-4-piperidinyl)-, (Z)-2-butenedioate (1:1),
UNII-K7SG01P7NJ,
KW 5617,
1,3-Dihydro-1-[1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]- benzoxazepin-4-yl)methyl]-4-piperidinyl]-2H-benzimidazol-2-one maleate,
K7SG01P7NJ,
MLS006010639,
AC1O51V4,
SCHEMBL1649784,
HMS3268F12,
HMS3677A04,
MFCD04113002,
AKOS024457009,
LS-33114,
SMR004701642,
CGS-9343B, >=98% (HPLC), powder,
(Z)-but-2-enedioic acid; 3-[1-[(4-methyl-6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)methyl]piperidin-4-yl]-1H-benzimidazol-2-one,
1,3-Dihydro-1-[1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)methyl]-4-piperidinyl]-2H-benzimidazol-2-one maleate,
1-[1-(4-Methyl-4H,6H-5-oxa-10b-aza-benzo[e]azulen-4-ylmethyl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one maleate,
Zaldaride,
Zy 27617B,
C26H28N4O2.C4H4O4,
CID6450522,
C26-H28-N4-O2.C4-H4-O4,
109826-26-8,